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Abstract 24 
Background: Diagnostic capacity and suboptimal logistics are consistently identified as barriers to 25 
timely diagnosis of cancer, especially lung cancer. Immediate chest X-ray (CXR) reporting for patients 26 
referred from general practice is advocated in the National Optimal Lung Cancer Pathway to improve 27 
time to diagnosis of lung cancer and to reduce inappropriate 2WW referrals. The aim of radioX is to 28 
examine the impact of immediate reporting by radiographers of CXRs requested by general practice, 29 
on lung cancer patient pathways. 30 
Methods: A two-way comparative study that will compare the time to diagnosis of lung cancer for 31 
patients. Internal comparison will be made between those who receive an immediate radiographer 32 
report of a GP CXR compared to standard radiographer GP CXR reporting over a 12 month period. 33 
External comparison will be made with a similar, neighbouring Trust that does not have radiographer 34 
CXR reporting. Primary outcome is the effect on the speed of the lung cancer pathway (diagnosis of 35 
cancer or discharge). Secondary outcomes include the effect of the pathway on efficiency including 36 
the number of repeat CXRs performed in a timely fashion for suspected infection and the effect of 37 
immediate reporting of GP CXRs on patient satisfaction. 38 
Discussion: The radioX trial will examine the hypothesis that immediate reporting of CXRs referred 39 
from general practice reduces the time to diagnosis of lung cancer or discharge from the lung cancer 40 
pathway. 41 
Trial registration: International Standard Randomised Controlled Trial Number ISRCTN21818068. 42 
Registered 20th June 2017 43 
 44 
 45 
  46 
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Background 47 
Lung cancer is the leading cause of cancer death worldwide.1 When compared to other common 48 
cancers, prognosis for lung cancer is worse.2 In the United Kingdom (UK) there has been a recent 49 
modest increase in survival, with 12.6% of patients with lung cancer surviving five years,3 although 50 
30% of patients die within 90 days of diagnosis.4 Diagnosis of lung cancer is often made at a late 51 
stage, when prognosis is poor,5 and several factors are thought to influence this. Symptoms 52 
suggesting lung cancer are often non-specific until late in the disease, which results in diagnostic 53 
difficulties in primary care.6 4 7 In an attempt to address this, recent guidance by the National 54 
Institute for Health and Care Excellence (NICE) has lowered the threshold for investigation and 55 
referral to specialist care for cases of possible malignancy, including lung cancer (NG12).8  56 
Imaging has become embedded into an increasing range of patient pathways, with the number of 57 
investigations performed in England doubling in nine years.9 Service challenges for radiology in the 58 
UK are threefold; sustained increases in activity,9 10 a chronic shortage of consultant radiologists11 12 59 
and unprecedented economic restrictions.13 Recognising the need to improve patient outcomes for 60 
cancer, especially lung cancer which has shown minimal improvement in survival rates,2 5 renewed 61 
focus is being given to rapid referral and diagnosis in cases of suspected cancer.6 8 14 These initiatives 62 
will undoubtedly increase the volume of imaging investigations performed, at a time when 63 
diagnostic capacity is failing to meet current demand.15  64 
A clinical report of imaging examinations is essential to guide diagnostic and treatment decisions. 65 
Time to a clinical report can be a serious factor in diagnostic delays16-18 with recognition that small 66 
delays for lung cancer diagnosis may contribute to higher stage at diagnosis19 and also a 67 
deterioration in performance status that may influence suitability for treatment. In the setting of the 68 
lung cancer pathway, delays are often multifactorial, but may be contributed to by the time taken to 69 
report a CXR. This is because the very first step in the lung cancer pathway is often the identification 70 
and reporting of a lung mass on a CXR, which should then trigger a staging computed tomogram 71 
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(CT). The use of appropriately trained radiographers to undertake clinical reporting is not new. 72 
Skeletal radiograph reporting, for example, has become widespread across the UK,12 20 and in many 73 
departments provides a significant contribution to reporting capacity.21 22 More recently, reporting 74 
radiographers have been trained to report CXRs23 24 and this has been proposed as a method of 75 
minimising CXR reporting times in patients with suspected lung cancer.25 There is some limited 76 
evidence to date that has evaluated CXR accuracy rates of trained reporting radiographers in 77 
comparison with radiologists. Reporting radiographers (n=40) were found to have high sensitivity 78 
(95.4%; 95% CI 94.4% - 96.3%) and specificity (95.9%; 95% CI 94.9% - 96.7%) at an objective 79 
structured examination of 100 CXRs at the completion of an accredited training programme.23   80 
 81 
Recent work found poor compliance with suggested optimal diagnostic investigations for lung 82 
cancer, with 23% of patients in England receiving investigation and results within the recommended 83 
timeframes with significant variation between regions.26 This study aims to evaluate the impact of 84 
radiographer reporting on the timeliness, accuracy and quality of CXR reports, as well as the impact 85 
on the overall lung cancer pathway in comparison with radiologists. These parameters have not 86 
previously been studied in lung cancer patients. The current study could act as a pilot study for a 87 
larger, multisite evaluation if results are positive. 88 
 89 
Methods 90 
The aim of the current study is to investigate the impact of radiographer immediate chest X-ray 91 
reporting on the lung cancer pathway.  92 
Trial Design 93 
A two-way comparative study that will compare the time to diagnosis of lung cancer for patients. 94 
Internal comparison will be made between those who receive an immediate radiographer report of 95 
a GP CXR compared to standard radiographer GP CXR reporting (Figure 1). The intervention group 96 
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will receive an immediate CXR report and be offered a CT for CXRs suspicious for cancer. The control 97 
group will have the CXR reported no later than next working day in line with current protocols. Key 98 
protocol elements are summarised in the SPIRIT (Standard Protocol Items: Recommendations for 99 
Interventional trials) 2013 checklist27 (Additional File 1) and Figure 2. 100 
 101 
The diagnostic aspect of the lung cancer pathway at Homerton University Hospital is relatively 102 
streamlined. To enable comparison with radiology service delivery at other institutions time to 103 
diagnosis (immediate and standard CXR reporting) will be compared with Newham University 104 
Hospital (Figure 2). This adjacent hospital has comparable patient demographics, a similar number of 105 
lung cancer patients per year and is of comparable size. Newham does not currently have CXR 106 
reporting radiographers and does not offer straight to CT for CXRs suspicious for lung cancer.  107 
Study Setting 108 
Research ethics committee and health research authority approval was granted 6 June 2017 (REC 109 
17/LO/0870; HRA 221968). This study will not directly recruit patients; it is an evaluation of health 110 
service delivery and as such no patient consent is required. Intervention is at an institutional level 111 
and institutional approval has been gained. No additional or different tests will be performed, and all 112 
the reporting practitioners (reporting radiographers and consultant radiologists) currently report 113 
CXRs in clinical practice. The comparative aspect of the study is the timing, accuracy and usefulness 114 
of the CXR report; immediate compared to standard care. Patient identifiable data will not be 115 
available outside of the direct clinical care team, only anonymised data will be used. Patients will be 116 
assigned a unique study identifier at time of CXR by the clinical care team. Block randomisation, 117 
institutional rather than patient enrolment and the use of de-identified data is in line with previous 118 
research that has examined the order of interpretation between readers.28 The intervention is 119 
considered to be an alternative non inferior form of standard practice since radiographer reporting 120 
of CXRs has already been implemented in some NHS Trusts in the UK. Radiographer reporting, 121 
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including CXRs, has been shown to create additional diagnostic capacity at centres that have 122 
embedded this into the imaging department.21 22 29 However, the published evidence on 123 
radiographer reporting of CXRs is limited. Furthermore robust methods of evaluating diagnostic 124 
reports (including actionability and usefulness) of radiographers and radiologists using independent 125 
experts has not previously been attempted.  126 
 127 
Clinical assessment will be made by a general practitioner and a referral made to Homerton 128 
University Hospital for a CXR examination following standard and established referral procedures. 129 
The referral for CXR will be checked by the performing radiographer or supervised assistant 130 
practitioner to ensure that the referral meets Ionizing Radiation (Medical Exposure) Regulations 131 
(IRMER) (2000) requirements and adheres to departmental protocols for a justified referral. Chest X-132 
rays will be obtained using digital radiography equipment, and radiation doses will be as low as 133 
possible whilst maintaining good image quality. Existing departmental imaging protocols will be 134 
followed. The standard X-ray projection for a chest examination is a single posterior-anterior (PA) X-135 
ray. The radiographer or assistant practitioner will check all images for diagnostic quality and record 136 
the radiation dose on the radiology information system (RIS) in line with department standard 137 
operating procedures. If the radiographer or assistant practitioner performing the CXR identifies a 138 
potentially significant abnormality, for example lung cancer or pneumothorax, this will be triaged for 139 
an immediate report according to current protocol.   140 
Inclusion and exclusion criteria are presented in Table 1. 141 
 142 
 Criteria 
Inclusion  Referred for a chest X-ray from general practice 
 Aged over 16 
 
Exclusion  Active diagnosis of lung cancer 
 
Table 1. Inclusion and exclusion criteria 143 
Randomisation 144 
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Intervention is at an institutional level; individual patients will not be randomised. Half-day sessions 145 
will be randomised to intervention or standard practice, using a randomisation list provided by the 146 
study statistician. This is in line with previous studies that have examined the timing or order of X-ray 147 
reading but where all examinations are requested as part of routine clinical care and receive reports 148 
from the same practitioners.30 149 
Intervention 150 
The intervention reporting strategy is modelled on the national optimal lung cancer pathway 151 
developed in 2016.31 The intervention strategy aims to streamline the patient journey through the 152 
lung cancer pathway by providing prompt interpretation of CXRs referred by general practice and 153 
offering immediate CT when appropriate. 154 
Chest X-rays included in the intervention arm will be reported at the time of image acquisition while 155 
the patient is still in the radiology department. Patients who have a CXR suspicious for cancer will be 156 
offered an immediate CT of the chest and upper abdomen. 157 
Control 158 
Current practice in most radiology departments is for general practitioner examinations to be 159 
reported once the patient has left the department. Considerable variability exists across England in 160 
the time taken to report X-ray examinations (report turnaround time; RTAT). At Homerton University 161 
Hospital, all GP X-rays are reported during the next reporting session following examination, with a 162 
maximum RTAT of 1 working day. Patients who have a CXR suspicious for cancer are offered an 163 
appointment for a CT of the chest and upper abdomen via the radiology department secretary team, 164 
with the results sent to the referring GP and the cancer referrals office. Current practice is that if a 165 
suspected abnormality is identified by the radiographer that performs the CXR an urgent report 166 
(reporting radiographer or consultant radiologist) is arranged while the patient is still in the 167 
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department. If the findings are suspicious for lung cancer the patent is offered a CT of the chest and 168 
abdomen. This protocol will continue throughout the study for the control reporting sessions. 169 
Outcome measures 170 
The primary outcome is to test the impact of radiographer immediate reporting of GP CXRs, with 171 
immediate CT where appropriate, on time from performance of the CXR to treatment (with 172 
intermediate time points)/discharge for lung cancer.  173 
Secondary outcome measures include: 174 
 Measurement of the effect on the speed of the lung cancer pathway: 175 
i. 6 and 12 month survival (lung cancer and all-cause) 176 
ii. Number of emergency admissions for lung cancer 177 
iii. Performance status at time of decision to treat 178 
iv. Stage at diagnosis of lung cancer 179 
 Measurement of the effect of the pathway on efficiency including: 180 
i. The impact of immediate GP CXR reporting on the number of urgent respiratory 181 
cancer (2WW) referrals 182 
ii. The accuracy and usefulness of radiographer CXR reporting in clinical practice 183 
iii. The cost effectiveness of radiographer reporting 184 
iv. The influence of immediate GP CXR reporting, with immediate CT where 185 
appropriate, on the number of first 2WW appointments with all radiology results 186 
available 187 
 Measurement of the number of repeat CXRs performed in a timely fashion for suspected 188 
infection 189 
 The effect of immediate reporting of GP CXRs on patient satisfaction 190 
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In addition to comparison as per randomisation within Homerton University Hospital, primary 191 
outcomes will be compared with a neighbouring hospital, Newham University Hospital.  192 
Components of the chest X-ray reporting pathway 193 
Reporting radiographer chest X-ray report 194 
All reporting radiographers participating in the study have completed an accredited postgraduate 195 
certificate in adult CXR reporting (experience 1 – 8 years) and currently provide CXR reports in 196 
clinical practice. All CXRs referred by general practice on eligible patients (>16 years, no active 197 
history of lung cancer) will receive a reporting radiographer report. In line with current practice, a 198 
narrated report will be provided rather than a structured report. Image interpretation will occur on 199 
Picture Archiving and Communication System (PACS) workstations and the report entered into PACS 200 
and transferred to the patient electronic record. If the reporting radiographer requires additional 201 
investigations (repeat X-ray due to inadequate initial X-ray, additional X-ray view, CT of the chest and 202 
abdomen), these will be arranged by the reporting radiographer at time of the CXR report.  203 
Off protocol radiographer reporting 204 
Where the radiographer performing the CXR is concerned about the appearance of the X-ray or by 205 
the clinical condition of the patient, current practice at Homerton University Hospital is for the CXR 206 
to be reviewed by a reporting radiographer or consultant radiologist prior to the patient leaving the 207 
department. This includes, for example, where the radiographer suspects a pneumothorax, 208 
tuberculosis or cancer. If a radiographer has concerns that the appearances of the CXR is abnormal 209 
and a significant pathology may be present, these patients will receive an immediate report, 210 
regardless of the reporting session allocation (immediate/standard) so as not to negatively impact 211 
on patient management. All such occurrences will be identified, included in the intention to treat 212 
principle but we will also carry out sensitivity analysis excluding them. In view of randomisation, we 213 
expect the same rates of such cases in intervention and control sessions.  214 
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Equivocal reporting radiographer reports 215 
For cases where the reporting radiographer is unsure with the findings and/or clinical significance of 216 
the CXR they will be free to review the case with another reporting radiographer and/or consultant 217 
radiologist. This is in line with current best practice. This will include for example, instances where 218 
previous cross sectional imaging is available for the patient, or where there may be unfamiliar 219 
medical terminology on the CXR request form. All occurrences will be recorded.  220 
Consultant radiologist chest X-ray report 221 
All CXRs will receive a consultant radiologist report (general radiologists; experience range 2 – 21 222 
years post FRCR), blinded to the reporting radiographer CXR report. Consultant radiologist reporting 223 
will occur at the next session following the reporting radiographer report. Interpretation will occur 224 
using PACS workstations and the report will be entered into a secure database.  225 
Comparison of radiographer and radiologist reports 226 
The CXR reports generated by the reporting radiographers and consultant radiologists will be 227 
extracted, anonymised for source of report (radiographer/radiologist) and entered into a secure 228 
database using the unique study identifier. A respiratory physician will compare the reports for 229 
discrepancies, using a proforma with predefined criteria for clinically significant abnormalities. 230 
Discrepancies in observations, interpretations and recommendations will be highlighted. These 231 
criteria have been previously validated.32 Report comparison will occur within 3 working days of the 232 
CXR examination. 233 
Additional radiology investigations 234 
All additional radiology investigations will be organised by the radiology department following 235 
established departmental operating procedures. These additional investigations would be 236 
performed as part of routine clinical practice and will not require any additional radiation exposure. 237 
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The reporting radiographers, after appropriate training, have been designated ‘Non-Medical 238 
Referrers’ according to IRMER 2000 legislation.  239 
Repeat chest X-ray for suspected infection 240 
According to British Thoracic Society (BTS) guidance,33 patients who have a CXR that is suspicious for 241 
infection require a follow up CXR six weeks later following antibiotics to ensure resolution. The 242 
reporting radiographer will arrange the follow up CXR at the time of the initial CXR report for the 243 
immediate reporting arm, and the patient will be asked to re-attend the radiology department in six 244 
weeks. This will be communicated in the CXR report.  245 
For patients who have a CXR suspicious for infection in the standard care arm the recommendation 246 
for a follow up CXR in six weeks will be included in the report conclusion. This will be requested by 247 
the general practitioner, as is current practice. 248 
CT of the chest 249 
Patients that have an abnormal CXR suspicious for cancer will have a CT of the chest performed. The 250 
reporting practitioner (reporting radiographer or consultant radiologist) will arrange this following 251 
standard department procedure. The CT scan forms part of routine clinical management and 252 
therefore does not require any additional radiation exposure. A consultant radiologist will interpret 253 
all CTs. 254 
The CT performed will be stratified based on the CXR appearances and the likelihood of cancer. This 255 
will minimize radiation exposure, in line with best practice. For patients with a CXR that is suspicious 256 
but not categorical for lung cancer a low dose unenhanced CT of the chest will be performed. For 257 
patients who have a CXR that shows a high likelihood of cancer, a CT of the chest and abdomen with 258 
intravenous contrast will be offered 259 
Index diagnosis by thoracic radiologist 260 
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Chest X-rays that are found to have discordant reporting radiographer and consultant radiologist 261 
reports at peer review will have an index diagnosis. For cases that have undergone a subsequent CT 262 
scan of the chest and abdomen, the CT report will constitute the index diagnosis. CXR reports, either 263 
reporting radiographer or consultant radiologist, will be deemed a true positive if CT confirms the 264 
CXR diagnosis and a false positive if the CT is normal or another pathology is demonstrated. True 265 
positive and true negative will be a consensus decision and corroboration between the CT and 266 
clinical history between a respiratory physician and a thoracic radiologist. Assessment of report 267 
accuracy will be made blinded to the origin (reporting radiographer/consultant radiologist) of the 268 
CXR report. 269 
For cases that have not had a CT performed, an independent expert thoracic consultant radiologist 270 
will constitute the index diagnosis. The index radiologist will feed back the diagnosis via a 271 
standardised proforma. All available thoracic imaging (X-ray, CT) for the patient will be sent via the 272 
Image Exchange Portal (IEP) to the Royal Brompton Hospital. IEP is an established, secure method of 273 
transferring radiology cases for external review within the NHS. A thoracic consultant radiologist will 274 
review the available imaging and provide the definite diagnosis. CXR reports, both reporting 275 
radiographer and consultant radiologist, will be deemed a true positive if the thoracic radiologist 276 
confirms the CXR diagnosis and a false positive if the thoracic radiologist interpretation is normal or 277 
another pathology is demonstrated. 278 
Statistical Considerations 279 
Sample size 280 
For the primary endpoint in this pilot study, time to treatment decision for lung cancers, if we expect 281 
an eleven day advance in time to first treatment decision, with a standard deviation of 14 (previous 282 
audit data suggest this degree of variation), 26 cancers in each group will confer 80% power (2-sided 283 
testing, 5% significance level), for the internal randomized comparison. We expect around 50 284 
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cancers per year in HUH, so we will have adequate power for this difference. A reduction in time to 285 
diagnosis of two weeks was found to improve mortality of lung cancer patients so this difference 286 
could be clinically significant in the current pilot study.34 If we anticipate a 12-day instead of 11-day 287 
advance in diagnosis, we would only need 22 in each arm, 44 cancers in all, for 80% power. For the 288 
external comparison, assuming Newham University Hospital has a similar number of lung cancers 289 
per year, therefore we would have close to 90% power for the same difference and standard 290 
deviation.  If we also compare times to diagnosis for all persons referred to the pathway (lung cancer 291 
and non-lung cancer diagnoses), previous data suggest an average of 18 days and a standard 292 
deviation of 14. If the intervention improves this by 7 days on average, with a standard deviation of 293 
15, we would need 73 subjects in each group referred to the pathway to achieve 80% power (2-sided 294 
testing, 5% significance level). Thus, both the internal and external comparisons will be adequately 295 
powered. 296 
Data analysis 297 
Times to diagnosis, treatment and other continuous outcomes will be compared using simple t-tests. 298 
Categorical outcomes, such as proportions of emergency admissions, will be compared using Poisson 299 
regression. Survival will be compared using proportional hazards regression. Patient satisfaction will 300 
be recorded in categorical outcomes, and will be compared using non-parametric tests. 301 
Patient satisfaction 302 
Patients referred for a CXR from general practice will be identified by the radiology administration 303 
team, as is current practice. Eligible patients will have a patient satisfaction survey posted to their 304 
home address, with a stamped self-addressed return envelope. No patient identifiable data will be 305 
collected. Comparison will be made between patients who received an immediate and routine CXR 306 
report. The patient satisfaction survey to be used has been included as Appendix 1. 307 
Health Economic Assessment 308 
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Adaptation of a health economic model that examined the impact of radiographer CXR reporting on 309 
the lung cancer pathway will be performed.35 The model for this project will map out the care 310 
pathways following standard reporting and immediate reporting. It is assumed that differences in 311 
time to treatment will affect severity and hence costs and quality of life. Costs will be calculated 312 
from an NHS perspective, covering a one-year period, and include X-ray reporting time, CXR cancer 313 
and non-cancer diagnostic accuracy, subsequent care costs, as well as reading and supervision costs . 314 
The cost per case detected will be reported. Quality of life scores will be obtained from the literature 315 
for different cancer stages and these will be used to generate quality-adjusted life years (QALYs). 316 
One way and probabilistic sensitivity analyses will be conducted to assess the impact on costs and 317 
cost-effectiveness of changing parameters in the model. Due to the timing of the intervention in 318 
relation to the lung cancer pathway there may be no meaningful difference in QALYs for the internal 319 
comparison. The reduction in time to a non-lung cancer diagnosis may be a worthwhile 320 
improvement in quality of life.   321 
Discussion 322 
The current study will determine the effect of immediate reporting of CXRs referred from general 323 
practice, with immediate CT where appropriate, on the time to diagnosis of lung cancer. Although 324 
only one part of the patient pathway, immediate GP CXR reporting could positively impact lung 325 
cancer diagnosis and outcomes in at least three ways:  Firstly, by providing an immediate CXR report 326 
and initiating earlier further investigation including CT, the time to diagnosis will be shortened. 327 
There is debate within the literature as to the significance of this in terms of improvements in early 328 
survival times, performance status and reducing emergency admissions.34 The current study will 329 
examine this, both with internal and external comparison. Secondly, the efficiency of the service 330 
may be improved by reducing the number of lung cancer pathway referrals through early provision 331 
of an alternative diagnosis, which in turn means less time for patient anxiety and distress. Thirdly, 332 
the proposal may release consultant radiologist time that can instead be used to interpret more 333 
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complex cross sectional imaging and support interventional procedures including lung biopsy. A 334 
reduction in average time to diagnosis for lung cancer will help centres meet the ambitious target of 335 
90% of lung cancer patients definitively diagnosed within 28 days by 2020.14 336 
Diagnostic capacity is a significant barrier to improved outcomes for cancer patients,14 36 with 337 
prompt radiology reports a particular issue across England.15 18 338 
The limitations of the current study include the fact that the intervention occurs only at a single 339 
clinical site at which the diagnostic aspect of the lung cancer pathway is already relatively 340 
streamlined. This is addressed by external comparison with a neighboring hospital with similar 341 
patient characteristics and a comparable number of lung cancers diagnosed annually.  342 
 343 
Trial Status 344 
Study protocol version 1.5 2nd May 2017. Study will commence 1st July 2017 and close 30th June 345 
2018. Trial registered ISRCTN21818068 20th June 2017. 346 
List of Abbreviations 347 
2WW  Urgent respiratory medicine referral for suspected cancer 348 
BTS  British Thoracic Society 349 
CXR  Chest X-ray 350 
CT  Computed Tomography 351 
GP  General Practice 352 
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IRMER 2000 Ionizing Radiation (Medical Exposure) Regulations 354 
16 
 
NHS  National Health Service 355 
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Figure list and legend 485 
Figure 1. Intervention and standard patient pathway at Homerton University Hospital and Newham 486 
General Hospital (external comparator) 487 
GP = general practitioner; CXR = chest X-ray; CT = computed tomography; RR = reporting 488 
radiographer; CR = consultant radiologist; Other Resp = other respiratory disease; sus CA = 489 
suspicious for cancer; 2WW = urgent respiratory referral for suspected cancer; Routine Resp = 490 
routine referral to respirator medicine 491 
 492 
Figure 2. Schedule of enrolment, interventions, and assessments. 493 
CXR = chest X-ray; CT = CT scan; * = when required   494 
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Appendix 1 – Patient Satisfaction Survey 495 
 496 
Homerton University Hospital strives to offer effective, patient focused healthcare. In order to 497 
improve services we would value your feedback on your experiences when you recently attended 498 
the Radiology department for a chest X-ray. Please indicate your response to each question by 499 
circling the appropriate answer. 500 
All answers are anonymous and confidential. If you have any questions please contact Dr Nick 501 
Woznitza, radiographer, on 0208 510 7848.  502 
Please return the completed survey in the stamped, self-addressed envelope provided. 503 
 504 
Q1 What is your gender? 505 
Male 506 
Female 507 
Prefer not to answer 508 
 509 
Q2 Which age group do you belong to? 510 
16-24 511 
25-34 512 
35-44 513 
45-54 514 
55-64 515 
65-74 516 
75-84 517 
85+ 518 
 519 
  520 
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Q3 To which of these ethnic groups do you consider you belong? 521 
White  522 
1. English / Welsh / Scottish / Northern Irish / British  523 
2. Irish  524 
3. Gypsy or Irish Traveller  525 
4. Any other White background, please describe  526 
Mixed / Multiple ethnic groups  527 
5. White and Black Caribbean  528 
6. White and Black African  529 
7. White and Asian  530 
8. Any other Mixed / Multiple ethnic background, please describe  531 
Asian / Asian British  532 
9. Indian  533 
10. Pakistani  534 
11. Bangladeshi  535 
12. Chinese  536 
13. Any other Asian background, please describe  537 
Black / African / Caribbean / Black British  538 
14. African  539 
15. Caribbean  540 
16. Any other Black / African / Caribbean background, please describe  541 
Other ethnic group  542 
17. Arab  543 
18. Any other ethnic group, please describe 544 
Prefer not to answer 545 
 546 
  547 
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Q4 When were you told that the results of your chest X-ray would be available? 548 
Immediately – given by a radiographer 549 
Immediately – to contact my GP 550 
Next day – to contact my GP 551 
 552 
Q5 Did you require any further tests? 553 
Yes – done at the same time as the chest X-ray 554 
Yes – done on another day after the chest X-ray 555 
No 556 
 557 
Q6 How do you feel about how you were told that you needed further tests? 558 
I did not need any further tests 559 
It was done sensitively 560 
It could have been done a bit more sensitively 561 
It could have been done a lot more sensitively 562 
 563 
Q7 How did you feel about needing further tests? 564 
Frightened 565 
Angry 566 
Upset 567 
Pleased that something was happening 568 
Prefer not to say 569 
Any comments? 570 
 571 
 572 
 573 
 574 
 575 
 576 
  577 
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Q8 Would you have liked to be contacted by your own GP (Doctor) before the CT scan – even 578 
if this meant a delay to your scan? 579 
Yes 580 
No 581 
Not sure 582 
Prefer not to say 583 
 584 
Q9 How long did you wait for your results after you had your CT scan? 585 
Less than a week 586 
1 – 2 weeks 587 
More than 2 weeks 588 
Can’t remember 589 
 590 
Q10 If you had an appointment, was the booking system flexible enough for you? 591 
My scan was performed immediately 592 
Yes 593 
No 594 
Don’t know/Can’t remember 595 
 596 
Q11 If you have any suggestions or comments about the service you would like to make, please 597 
use the space below 598 
 599 
 600 
 601 
